Advertisement
Large survey shows wide variability in risk tolerance, high levels of risk aversion
Patients who fail two or more antiepileptic meds should be referred for evaluation
Pilot program expedites patient transfers by removing precertification requirements
In vitro model of blood-brain barrier points to potential therapeutic target
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Honor recognizes imaging and therapeutic insights behind slowing of brain atrophy
Any benefits are inconclusive while harms are well established
Study signals potential for enhanced patient monitoring
Much-needed endovascular alternatives to open surgery are emerging
Cleveland Clinic IND application is first approved in Parkinson’s and Alzheimer’s
Course honoring the master neurosurgeon packs a substantive punch
Advertisement
Advertisement